Skip to Navigation
Skip to Main Content
Agency Directory
|
Phone Directory
|
Online Services
Search BMS
Agency Directory
|
Phone Directory
|
Online Services
Buprenorphine
DUR
P&T Committee
Preferred Drug List
State Max Allowable Costs
Search BMS
WVDHHR
>
Bureau for Medical Services
>
Pharmacy
>
DUR
>
DUR Board Meetings
DUR Board Meetings
Page Content
Contact
: Priya Shah, Pharm D
Drug Utilization Review Coordinator
304-558-1700
Priya.B.Shah@wv.gov
2025 Meetings
February 26, 2025
(Virtual Meeting Only)
Agenda
2024 Meetings
November 13, 2024
(Virtual Meeting Only)
Agenda
Minutes
Public Comment 1
Public Comment 2
Public Comment 2a
Public Comment 2b
Attachment A- Gainwell Technologies Report
Attachment B - RDTP Quarterly Criteria
Attach
men
t
C - Kepro Quarterly Report
September 25, 2024
(Virtual Meeting Only)
Agenda
Minutes
Public Comment 1
Public Comment 2
Public Comment 2a
Public Comment 2b
Public Comment 2c
Attachment A- PA Criteria
Attachment B- Gainwell Technologies Report
Attachment C- RDTP Quarterly Criteria
Attachmen
t
D- Acentra Quarterly Report
May 22, 2024
(Virtual Meeting Only)
Agenda
Minutes
Public Comment 1
Attachment A - Prior Authorization Criteria
Attachment B - Gainwell Technologies Report
Attachment C - RDTP Quarterly Criteria
A
ttachmen
t
D - Acentra Quarterly Report
February 14, 2024
(Virtual Meeting Only)
Agenda
Minutes
Attachment A- Prior Authorization Criteria
Attachment B- Gainwell Technologies Report
Attachment C- RDTP Quarterly Criteria
Attachment D - Acentra Health (formerly Kepro) Quarterly Report